• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Abbott FreeStyle Libre named ‘best medical technology’ in last 50 years by Galien Foundation

October 28, 2022 By Sean Whooley

Abbott FreeStyle Libre 3 sensor pennies CGM diabetes
The sensor for the next-generation FreeStyle Libre 3 CGM is the same size as two U.S. pennies stacked together. [Image courtesy of Abbott]
Abbott (NYSE:ABT) announced today that the Galien Foundation picked its FreeStyle Libre continuous glucose monitor (CGM) for a major award.

The foundation named FreeStyle Libre as the best “Best Medical Technology” of the last 50 years. Other medtech receiving the designation included Edwards Lifesciences’ Sapien 3 Ultra TAVR and Roche’s Cobas HPV test.

This announcement came at the Prix Galien Golden Jubilee Awards ceremony last night in New York City. The foundation picked award winners across five categories from 250 products awarded the Prix Galien between 1970 and 2019.

According to a news release, Prix Galien is regarded as the equivalent of the Nobel Prize for biopharmaceutical and medical technology research. FreeStyle Libre received the 2019 Prix Galien USA Award for Best Medical Technology.

“The Prix Galien Golden Jubilee Awards honor the global ‘best of the best’ innovations that have improved the human condition over the last 50 years,” said Bruno Cohen, chair of the Galien Foundation. “The companies behind these amazing innovations have a bold passion for change, which has led to the development of life-saving products.”

(Go to Medical Design & Outsourcing to find out the medical technology honored as the best of 2022.)

About Abbott’s FreeStyle Libre

Abbott received 11 Prix Galien Awards in its history. Those awards include its Humira, MitraClip and FreeStyle Libre offerings.

FreeStyle Libre 3 picked up FDA clearance for people with diabetes aged four years old and up in May. The latest-generation device from Abbott is the smallest and thinnest CGM sensor in the world. It comes at the size of just two stacked pennies.

Data presented in June demonstrated an overall MARD of 7.9%. Abbott said that made FreeStyle Libre 3 the first and only 14-day CGM to achieve a sub-8% overall MARD. FreeStyle Libre 3’s recent launch boosted the company’s third-quarter sales.

More recent data for the FreeStyle Libre platform demonstrated reduced hospitalizations and lowered HbA1c.

“Abbott’s FreeStyle Libre portfolio has revolutionized how people live with diabetes, eliminating the need for traditional fingersticks,” said Jared Watkin, SVP of Abbott’s diabetes care business. “Today, approximately 4.5 million people around the world use this life-changing technology to manage their diabetes and improve health outcomes, helping them live fuller, healthier lives every day.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Galien Foundation

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS